Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity

Acetaminophen (APAP) hepatotoxicity because of overdose is the most frequent cause of acute liver failure in the western world. Metabolic activation of APAP and protein adduct formation, mitochondrial dysfunction, oxidant stress, peroxynitrite formation and nuclear DNA fragmentation are critical intracellular events in hepatocytes. However, the early cell necrosis causes the release of a number of mediators such as high‐mobility group box 1 protein, DNA fragments, heat shock proteins (HSPs) and others (collectively named damage‐associated molecular patterns), which can be recognized by toll‐like receptors on macrophages, and leads to their activation with cytokine and chemokine formation. Although pro‐inflammatory mediators recruit inflammatory cells (neutrophils, monocytes) into the liver, neither the infiltrating cells nor the activated resident macrophages cause any direct cytotoxicity. In contrast, pro‐ and anti‐inflammatory cytokines and chemokines can directly promote intracellular injury mechanisms by inducing nitric oxide synthase or inhibit cell death mechanisms by the expression of acute‐phase proteins (HSPs, heme oxygenase‐1) and promote hepatocyte proliferation. In addition, the newly recruited macrophages (M2) and potentially neutrophils are involved in the removal of necrotic cell debris in preparation for tissue repair and resolution of the inflammatory response. Thus, as discussed in detail in this review, the preponderance of experimental evidence suggests that the extensive sterile inflammatory response during APAP hepatotoxicity is predominantly beneficial by limiting the formation and the impact of pro‐inflammatory mediators and by promoting tissue repair.

[1]  Dominic P. Williams,et al.  High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  H. Ohnishi,et al.  Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose. , 2003, Hepato-Gastroenterology.

[3]  Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen , 1995, Hepatology.

[4]  H. Jaeschke,et al.  Scavenging Peroxynitrite with Glutathione Promotes Regeneration and Enhances Survival during Acetaminophen-Induced Liver Injury in Mice , 2003, Journal of Pharmacology and Experimental Therapeutics.

[5]  A. Burlingame,et al.  Identification of the Hepatic Protein Targets of Reactive Metabolites of Acetaminophen in Vivo in Mice Using Two-dimensional Gel Electrophoresis and Mass Spectrometry* , 1998, The Journal of Biological Chemistry.

[6]  H. Jaeschke,et al.  Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  S. Thorgeirsson,et al.  Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. , 1974, Pharmacology.

[8]  F. Sutterwala,et al.  Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. , 2009, The Journal of clinical investigation.

[9]  Rosie Yu,et al.  Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis , 2000, Nature Biotechnology.

[10]  Y. Delneste,et al.  Pattern recognition receptors in the immune response against dying cells. , 2008, Current opinion in immunology.

[11]  G. Su,et al.  Lipopolysaccharide‐binding protein modulates acetaminophen‐induced liver injury in mice , 2005, Hepatology.

[12]  M. Shibuya,et al.  Vascular endothelial growth factor receptor-1 signaling promotes liver repair through restoration of liver microvasculature after acetaminophen hepatotoxicity. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  J. G. Thomson,et al.  MECHANICAL TRANSMISSION OF TRYPANOSOMIASIS, LEISHMANIASIS, AND YAWS THROUGH THE AGENCY OF NON-BITING HAEMATOPHAGOUS FLIES , 1934, British medical journal.

[14]  N. Mukaida,et al.  A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  N. Kaplowitz,et al.  Role of innate immunity in acetaminophen-induced hepatotoxicity , 2006, Expert opinion on drug metabolism & toxicology.

[16]  H. Jaeschke,et al.  Role of caspases in acetaminophen-induced liver injury. , 2006, Life sciences.

[17]  H. Jaeschke,et al.  Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[18]  A. Farhood,et al.  Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[19]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[20]  N. Kaplowitz,et al.  Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. , 2004, Gastroenterology.

[21]  H. Jaeschke Innate immunity and acetaminophen‐induced liver injury: Why so many controversies? , 2008, Hepatology.

[22]  S. Wrighton,et al.  Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[23]  A. Jacknowitz Possible effect of viral infections on drug metabolism. , 1984, JAMA.

[24]  A. Y. Lu,et al.  N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Akira,et al.  Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.

[26]  H. Jaeschke,et al.  Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and fas‐antibody–induced liver injury , 1998, Hepatology.

[27]  M. Monshouwer,et al.  Effect of Hepatitis C Virus Infection on the mRNA Expression of Drug Transporters and Cytochrome P450 Enzymes in Chimeric Mice with Humanized Liver , 2010, Drug Metabolism and Disposition.

[28]  Sack Rb Letter: Serotyping of E. coli. , 1976, Lancet.

[29]  N. Milošević,et al.  Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes. , 1999, European journal of pharmacology.

[30]  H. Jaeschke Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[31]  Yang Liu,et al.  CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses , 2009, Science.

[32]  H. Jaeschke,et al.  Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. , 1990, The Journal of pharmacology and experimental therapeutics.

[33]  D. Adams,et al.  Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.

[34]  N. Mukaida,et al.  A pivotal involvement of IFN‐' in the pathogenesis of acetaminophen‐induced acute liver injury , 2002 .

[35]  R. Ramsay,et al.  In vitro effects of acetaminophen metabolites and analogs on the respiration of mouse liver mitochondria. , 1989, Archives of biochemistry and biophysics.

[36]  J. Brady,et al.  A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. , 2001, Chemical research in toxicology.

[37]  C. Zwingmann,et al.  Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N‐acetylcysteine , 2010, Hepatology.

[38]  C. Cuff,et al.  Bacterial- and Viral-Induced Inflammation Increases Sensitivity to Acetaminophen Hepatotoxicity , 2009, Journal of toxicology and environmental health. Part A.

[39]  T J Bucci,et al.  Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. , 1991, The American journal of pathology.

[40]  H. Mehendale,et al.  Tissue Repair: An Important Determinant of Final Outcome of Toxicant-Induced Injury , 2005, Toxicologic pathology.

[41]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[42]  H. Jaeschke,et al.  Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. , 1991, Free radical research communications.

[43]  P. Simpson,et al.  Human Recombinant Vascular Endothelial Growth Factor Reduces Necrosis and Enhances Hepatocyte Regeneration in a Mouse Model of Acetaminophen Toxicity , 2010, Journal of Pharmacology and Experimental Therapeutics.

[44]  H. Jaeschke,et al.  Neutrophil depletion protects against murine acetaminophen hepatotoxicity: Another perspective , 2007, Hepatology.

[45]  D. Dix,et al.  Increased hepatotoxicity of acetaminophen in Hsp70i knockout mice. , 2006, Toxicology and applied pharmacology.

[46]  William M. Lee,et al.  AASLD Position Paper: The Management of Acute Liver Failure: Update 2011 , 2011 .

[47]  H. Jaeschke Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity , 2005, Expert opinion on drug metabolism & toxicology.

[48]  R. Kurten,et al.  Tumour necrosis factor receptor 1 and hepatocyte regeneration in acetaminophen toxicity: a kinetic study of proliferating cell nuclear antigen and cytokine expression. , 2005, Basic & clinical pharmacology & toxicology.

[49]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.

[50]  Hartmut Jaeschke,et al.  Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[51]  G. Su,et al.  Lipopolysaccharide binding protein inhibitory peptide protects against acetaminophen-induced hepatotoxicity. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[52]  A. Proudfoot,et al.  TREATMENT OF PARACETAMOL (ACETAMINOPHEN) POISONING WITH N-ACETYLCYSTEINE , 1977, The Lancet.

[53]  H. Jaeschke,et al.  Mitochondrial Bax Translocation Accelerates DNA Fragmentation and Cell Necrosis in a Murine Model of Acetaminophen Hepatotoxicity , 2008, Journal of Pharmacology and Experimental Therapeutics.

[54]  A. Shaheen,et al.  Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen‐related hepatotoxicity , 2009, Hepatology.

[55]  H. Jaeschke,et al.  Acetaminophen Toxicity in Mice Lacking NADPH Oxidase Activity: Role of Peroxynitrite Formation and Mitochondrial Oxidant Stress , 2003, Free radical research.

[56]  P. Simpson,et al.  Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[57]  D. Laskin,et al.  Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. , 2003, Toxicology and applied pharmacology.

[58]  Steven D. Cohen,et al.  Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin‐α gene knockout mice , 1998, Hepatology.

[59]  S. Diebold Innate recognition of viruses. , 2010, Immunology letters.

[60]  V. Dixit,et al.  Inflammasomes: guardians of cytosolic sanctity , 2009, Immunological reviews.

[61]  H. Jaeschke,et al.  Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion. , 2002, Toxicology and applied pharmacology.

[62]  Toshiharu Horie,et al.  Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. , 2005, Journal of hepatology.

[63]  L. Pohl,et al.  Protection against acetaminophen‐induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase , 2002, Hepatology.

[64]  D. Laskin,et al.  Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. , 1986, Toxicology and applied pharmacology.

[65]  H. Jaeschke,et al.  Role of neutrophils in acute inflammatory liver injury , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[66]  J. Brady,et al.  Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. , 2002, Chemical research in toxicology.

[67]  C. Smith,et al.  Antineutrophil monoclonal antibody (1F12) alters superoxide anion release by neutrophils and Kupffer cells , 1994, Journal of leukocyte biology.

[68]  Justina J. Sam,et al.  Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: A nationwide analysis , 2008, Hepatology.

[69]  R. Schwabe,et al.  Toll-like receptor signaling in the liver. , 2006, Gastroenterology.

[70]  H. Jaeschke,et al.  Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity. , 2006, Toxicology and applied pharmacology.

[71]  A. Farhood,et al.  The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[72]  H. Jaeschke,et al.  Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice. , 1999, Toxicology and applied pharmacology.

[73]  A. Burlingame,et al.  Identification of hepatic protein targets of the reactive metabolites of the non-hepatotoxic regioisomer of acetaminophen, 3'-hydroxyacetanilide, in the mouse in vivo using two-dimensional gel electrophoresis and mass spectrometry. , 2001, Advances in experimental medicine and biology.

[74]  D. Laskin,et al.  Role of CCR2 in macrophage migration into the liver during acetaminophen‐induced hepatotoxicity in the mouse , 2002, Hepatology.

[75]  N. Mukaida,et al.  Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen‐induced acute liver injury , 2006, European journal of immunology.

[76]  Steven D. Cohen,et al.  Selective protein covalent binding and target organ toxicity. , 1997, Toxicology and applied pharmacology.

[77]  U. Boelsterli,et al.  Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice. , 1998, Hepatology.

[78]  K. Renton,et al.  The prevention of acetaminophen-induced hepatotoxicity by the interferon inducer poly(rI . rC). , 1984, Toxicology and applied pharmacology.

[79]  F. O. Fackelmayer,et al.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.

[80]  J. Hinson,et al.  Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[81]  D. Pessayre,et al.  Subliminal Fas stimulation increases the hepatotoxicity of acetaminophen and bromobenzene in mice , 2004, Hepatology.

[82]  H. Jaeschke,et al.  Role of lipid peroxidation as a mechanism of liver injury after acetaminophen overdose in mice. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[83]  H. Jaeschke,et al.  Mitochondrial permeability transition in acetaminophen‐induced necrosis and apoptosis of cultured mouse hepatocytes , 2004, Hepatology.

[84]  L. James,et al.  Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. , 2003, Biochemical and biophysical research communications.

[85]  M. Bianchi,et al.  HMGB1 loves company , 2009, Journal of leukocyte biology.

[86]  D. Green,et al.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. , 2008, Immunity.

[87]  P. Ghezzi,et al.  Depression of hepatic drug metabolism in endotoxin-treated and sarcoma-bearing mice. , 1992, Research communications in chemical pathology and pharmacology.

[88]  M. Croyle Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem , 2009, Expert opinion on drug metabolism & toxicology.

[89]  M. Vail,et al.  Enhanced acetaminophen hepatotoxicity in transgenic mice overexpressing BCL-2. , 2001, Molecular pharmacology.

[90]  R. MacLaren,et al.  Lactoferrin protects against acetaminophen‐induced liver injury in mice , 2010, Hepatology.

[91]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[92]  C. J. Dunn,et al.  Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. , 1997, The American journal of physiology.

[93]  J. Spitzer,et al.  Superoxide Anion Generation in the Liver During the Early Stage of Endotoxemia in Rats , 1990, Journal of leukocyte biology.

[94]  Steven D. Cohen,et al.  Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. , 1988, Toxicology and applied pharmacology.

[95]  H. Jaeschke,et al.  Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[96]  Yoshiya Ito,et al.  Early Hepatic Microvascular Injury in Response to Acetaminophen Toxicity , 2003, Microcirculation.

[97]  H. Jaeschke,et al.  Peroxynitrite Is a Critical Mediator of Acetaminophen Hepatotoxicity in Murine Livers: Protection by Glutathione , 2002, Journal of Pharmacology and Experimental Therapeutics.

[98]  D. Laskin,et al.  Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin. , 2002, Toxicology and applied pharmacology.

[99]  H. Jaeschke,et al.  Peroxynitrite formation and sinusoidal endothelial cell injury during acetaminophen-induced hepatotoxicity in mice , 2004, Comparative hepatology.

[100]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.

[101]  H. Jaeschke,et al.  Acetaminophen‐induced hepatic neutrophil accumulation and inflammatory liver injury in CD18‐deficient mice , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[102]  J. Caldwell,et al.  Effect of poly rI:rC treatment upon the metabolism of [14C]-paracetamol in the BALB/cJ mouse. , 1987, Biochemical pharmacology.

[103]  C. Smith,et al.  ACTIVATION OF KUPFFER CELLS AND NEUTROPHILS FOR REACTIVE OXYGEN FORMATION IS RESPONSIBLE FOR ENDOTOXIN-ENHANCED LIVER INJURY AFTER HEPATIC ISCHEMIA , 1995, Shock.

[104]  H. Jaeschke,et al.  The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. , 2003, Toxicology letters.

[105]  H. Jaeschke,et al.  Diurnal fluctuation and pharmacological alteration of mouse organ glutathione content. , 1985, Biochemical pharmacology.

[106]  S. Ray,et al.  Early loss of large genomic DNA in vivo with accumulation of Ca2+ in the nucleus during acetaminophen-induced liver injury. , 1990, Toxicology and applied pharmacology.

[107]  D. Laskin,et al.  Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. , 2003, Toxicology and applied pharmacology.

[108]  Michael P Holt,et al.  The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. , 2010, Toxicology letters.

[109]  T. D. Bell,et al.  ALTERED THEOPHYLLINE PHARMACOKINETICS DURING ACUTE RESPIRATORY VIRAL ILLNESS , 1978, The Lancet.

[110]  Hartmut Jaeschke,et al.  Intracellular signaling mechanisms of acetaminophen-induced liver cell death. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[111]  L. Prescott,et al.  Liver damage and impaired glucose tolerance after paracetamol overdosage. , 1966, British medical journal.

[112]  D. Laskin Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. , 2009, Chemical research in toxicology.

[113]  S. Akira,et al.  A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release , 2010, Proceedings of the National Academy of Sciences.

[114]  Ivan Rusyn,et al.  Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans. , 2009, Genome research.

[115]  K. Sasaki,et al.  Antidotal effect of lipopolysaccharide against acetaminophen-induced mortality in mice. , 1990, Pharmacology & toxicology.

[116]  R. Wilson,et al.  Role of proinflammatory cytokines in acetaminophen hepatotoxicity. , 1995, Toxicology and applied pharmacology.

[117]  H. Jaeschke,et al.  Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury. , 2010, Toxicology and applied pharmacology.

[118]  Dominic P. Williams,et al.  Diet Restriction Inhibits Apoptosis and HMGB1 Oxidation and Promotes Inflammatory Cell Recruitment during Acetaminophen Hepatotoxicity , 2010, Molecular medicine.

[119]  William M. Lee,et al.  Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice. , 2010, Biochemical pharmacology.

[120]  M. Tirmenstein,et al.  Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. , 1989, The Journal of biological chemistry.

[121]  N. Kaplowitz,et al.  Neutrophil depletion protects against murine acetaminophen hepatotoxicity , 2006, Hepatology.

[122]  C. Klaassen,et al.  Endotoxin pretreatment protects against the hepatotoxicity of acetaminophen and carbon tetrachloride: role of cytochrome P450 suppression. , 2000, Toxicology.

[123]  H. Jaeschke,et al.  Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury , 2011, Free radical research.

[124]  L. Pohl,et al.  Pathogenic role of natural killer T and natural killer cells in acetaminophen‐induced liver injury in mice is dependent on the presence of dimethyl sulfoxide , 2008, Hepatology.

[125]  Michael P Holt,et al.  Identification and characterization of infiltrating macrophages in acetaminophen‐induced liver injury , 2008, Journal of leukocyte biology.

[126]  D. Hume,et al.  The mononuclear phagocyte system of the pig as a model for understanding human innate immunity and disease , 2011, Journal of leukocyte biology.

[127]  William M. Lee,et al.  Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study , 2005, Hepatology.

[128]  N. Pumford,et al.  Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species , 1999, Hepatology.

[129]  Dirk E. Smith,et al.  The IL-1 family: regulators of immunity , 2010, Nature Reviews Immunology.